Search / Trial NCT06227468

A Clinical Study to Map the HLA Genomic Region in the Greek Population

Launched by ATHENS LIFETECH PARK · Jan 25, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Description

The GENESIS study is a multicenter, prospective, non-interventional, clinical study with a target of 12,000 subjects and an anticipated total duration of 36 months. The aim of study GENESIS is to provide a pilot map of HLA genetic variation in the Greek population in order to be used in medical research and for possible clinical applications (evaluation of possible correlations with selected underlying diseases). During the study, each subject will conduct one visit to the participating cite, in which they will provide: 1. Demographic information \[i.e. date of birth, gender, race, ancestr...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The study will include adult subjects (age ≥ 18) that:
  • * possess a Greek social security number and are visiting hospitals/clinics, and/or other private laboratory institutions (incl. clinics and health care groups) as part of standard clinical practice in Greece,
  • * are willing and able to provide written informed consent to participate in the study according to the study protocol.
  • Exclusion Criteria:
  • * Subjects not able to provide written informed consent (e.g. ICU patients, mental illness patients, lack of legal capacity).
  • * Subjects who have had an allogeneic (non-self-donor):
  • * bone marrow transplant
  • * stem cell transplant
  • * blood transfusion less than two weeks prior to buccal swab sample collection
  • * liver transplant
  • * Subjects who participated in an interventional clinical trial in the past that according to the subject's physician opinion might have had an impact on their HLA genome.

About Athens Lifetech Park

Athens Lifetech Park is a leading clinical trial sponsor dedicated to advancing innovative healthcare solutions through rigorous research and development. Situated in Athens, Greece, the organization fosters collaboration among biotech, pharmaceutical, and medical device companies to accelerate the translation of scientific discoveries into effective treatments. With a strong focus on quality and compliance, Athens Lifetech Park is committed to conducting ethically sound and scientifically robust clinical trials that aim to improve patient outcomes and enhance the overall healthcare landscape.

Locations

Chaidari, Attiki, Greece

Thessaloníki, Thessaloniki, Greece

Alexandroupolis, Thrace, Greece

Alexandroupolis, , Greece

Heraklion, , Greece

Heraklion, , Greece

Ioannina, , Greece

Larissa, , Greece

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0